We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Greiner Bio-One

The Preanalytics division develops, manufactures and distributes venous blood collection devices for hospitals, labor... read more Featured Products: More products

Download Mobile App





Greiner Bio-One Introduces Next Generation Urine Diagnostics

By LabMedica International staff writers
Posted on 29 Jul 2025

Greiner Bio-One (Kremsmünster, Austria) is exhibiting its latest advancements at ADLM 2025, which also marks the debut of its new urinalysis tube that offers room-temperature sample stability up to 72 hours. More...

At ADLM 2025, Greiner Bio-One will debut the VACUETTE Urine STB tube, which offers a standardized solution to ensure the stability of urinalysis samples by ensuring sample integrity. The all-new VACUETTE Urine STB Tube stabilizes key parameters for dipstick testing, clinical chemistry, and urine sediment analysis for up to 72 hours without refrigeration. VACUETTE Urine STB tubes contain a preservative made up of ethylparaben, chlorhexidine, and sodium propionate to inhibit bacterial and yeast growth and ensure the reliability of urinalysis results. This means a slow or delayed processing time during transport and storage will not affect the sample when it comes to sample quality and reliable analysis results, preventing the risk of preanalytical errors. The vacuum in the tube enables the optimal ratio of specimen sample to preservative. The tubes are available with a round or conical bottom for easier manual processing of the urinary sediment for microscopy analysis.

Greiner Bio-One is also sponsoring an Industry Workshop presented by Prof. Ana-Maria Simundic on the value that labs can deliver through patient blood management. Hospitalized patients are at high risk for developing hospital-acquired anemia (HAA). This session will focus on the methods labs may use to minimize patient blood loss and reduce HAA risk. Attendees will learn about the current landscape of patient blood management, explore available strategies and tools for minimizing patient blood loss, and discover possible benefits that may be achieved by implementing patient blood management interventions.

Related Links:
Greiner Bio-One


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
New
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dormant tumor cells evade imaging tests and may later reactivate to spread metastatic breast cancer (Photo courtesy of David A. Litman/Shutterstock)

MRD Testing Can Identify Breast Cancer Survivors at Higher Risk of Recurrence

Breast cancer survival rates continue to improve, but recurrence remains incurable and affects around 30% of patients. Some subtypes, like triple negative and HER2+, relapse within years, while ER+ cancers... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.